Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/11/20
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 MillionGlobeNewsWire • 10/13/20
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12PRNewsWire • 10/12/20
Eyenovia to Present Clinical Study Updates at the American Academy of Optometry Annual MeetingBusiness Wire • 10/05/20
Eyenovia to Present at the 22nd Annual H.C. Wainwright Global Investment ConferenceGlobeNewsWire • 09/09/20
Eyenovia, Inc. Announces Underwriters’ Full Exercise of Over-Allotment Option in Public OfferingGlobeNewsWire • 08/24/20
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/13/20
Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial ResultsGlobeNewsWire • 07/29/20
Eyenovia Resumes Recruitment of Phase III CHAPERONE Study for Progressive MyopiaGlobeNewsWire • 06/30/20
Eyenovia, Inc. Announces Adjournment of 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting FormatGlobeNewsWire • 06/11/20
Eyenovia Announces Intention to Adjourn 2020 Annual Meeting of Stockholders to June 30, 2020 and Change to a Virtual Meeting FormatGlobeNewsWire • 06/05/20
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
Eyenovia, Inc. (EYEN) CEO Sean Ianchulev on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/26/20
Eyenovia, Inc. Announces Closing of Approximately $6.0 Million Private PlacementGlobeNewsWire • 03/24/20